Disinfectant testing against human norovirus surrogates—What infection preventionists need to know

Categories: Articles & Healthcare November 1, 2018

PDI Healthcare’s Director of Laboratory Sciences, James Clayton, wrote on article on the testing against human norovirus surrogates.


Disinfectant testing against human norovirus surrogates – What infection preventionists need to know

Source: Cambridge University Press

Author: James Clayton

Excerpt:

“The EPA currently only allows virucidal claims against human norovirus to be made from data that demonstrates a disinfectant’s efficacy against feline calicivirus (FCV). Despite this, there are EPA-registered products that cite efficacy against murine norovirus (MNV) as the basis for their antinoroviral claims. The problem with these surrogates is that their response to sanitizers and disinfectants may not reflect the true behavior of human norovirus, a problem that the CDC recognizes for feline calicivirus.”